As of September 30, 2010
|
Pro Forma
|
Pro Forma
|
|||||||||||||||
PLX
|
Teranetics
|
Adjustments
|
Combined
|
||||||||||||||
ASSETS
|
|||||||||||||||||
Current Assets:
|
|||||||||||||||||
Cash and cash equivalents
|
$ | 25,100 | $ | 113 | $ | (922 | ) |
(a)
|
$ | 8,412 | |||||||
(15,879 | ) |
(b)
|
|||||||||||||||
Short-term investments
|
13,727 | - | - | 13,727 | |||||||||||||
Accounts receivable, net
|
12,921 | 442 | - | 13,363 | |||||||||||||
Inventories
|
14,168 | 444 | - | 14,612 | |||||||||||||
Other current assets
|
3,519 | 510 | (1,000 | ) |
(c)
|
2,879 | |||||||||||
(150 | ) |
(d)
|
|||||||||||||||
Total current assets
|
69,435 | 1,509 | (17,951 | ) | 52,993 | ||||||||||||
Property and equipment, net
|
11,452 | 673 | - | 12,125 | |||||||||||||
Goodwill
|
1,367 | - | 25,389 |
(e)
|
26,756 | ||||||||||||
Other purchased intangible assets
|
3,695 | - | 30,500 |
(f)
|
34,195 | ||||||||||||
In-process IPR&D
|
- | - | - | - | |||||||||||||
Long-term investments
|
4,305 | - | - | 4,305 | |||||||||||||
Other assets
|
2,192 | 42 | - | 2,234 | |||||||||||||
Total assets
|
$ | 92,446 | $ | 2,224 | $ | 37,938 | $ | 132,608 | |||||||||
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
|
|||||||||||||||||
Current Liabilities:
|
|||||||||||||||||
Accounts payable
|
$ | 7,320 | $ | 2,890 | $ | (1,247 | ) |
(b)
|
$ | 8,963 | |||||||
Line of credit
|
- | 2,262 | (1,000 | ) |
(c)
|
- | |||||||||||
(1,262 | ) |
(b)
|
|||||||||||||||
Convertible promissory note
|
- | 8,728 | (8,728 | ) |
(b)
|
- | |||||||||||
Accrued compensation and benefits
|
3,256 | 7,386 | (2,664 | ) |
(b)
|
6,631 | |||||||||||
(1,347 | ) |
(g)
|
|||||||||||||||
Accrued commissions
|
729 | - | - | 729 | |||||||||||||
Income taxes payable
|
812 | - | - | 812 | |||||||||||||
Short term capital lease obligation
|
1,131 | - | - | 1,131 | |||||||||||||
Deferred revenue
|
- | 500 | (500 | ) |
(d)
|
- | |||||||||||
Other accrued expenses
|
1,437 | 3,018 | (1,978 | ) |
(b)
|
2,477 | |||||||||||
Total current liabilities
|
14,685 | 24,784 | (18,725 | ) | 20,744 | ||||||||||||
Long-term capital lease obligation
|
295 | - | - | 295 | |||||||||||||
Long-term notes payable
|
- | - | 6,650 |
(h)
|
6,650 | ||||||||||||
Total liabilities
|
14,980 | 24,784 | (12,075 | ) | 27,689 | ||||||||||||
Stockholders' equity (deficit):
|
|||||||||||||||||
Convertible preferred stock
|
- | 62,047 | (62,047 | ) |
(i)
|
- | |||||||||||
Common stock
|
37 | 27 | 7 |
(j)
|
44 | ||||||||||||
(27 | ) |
(i)
|
|||||||||||||||
Additional paid-in capital
|
155,098 | 32,565 | 27,447 |
(j)
|
182,545 | ||||||||||||
(32,565 | ) |
(i)
|
|||||||||||||||
Accumulated other comprehensive income
|
(122 | ) | - | - | (122 | ) | |||||||||||
Accumulated deficit
|
(77,547 | ) | (117,199 | ) | 117,199 |
(i)
|
(77,547 | ) | |||||||||
Total stockholders' equity (deficit)
|
77,466 | (22,560 | ) | 50,014 | 104,920 | ||||||||||||
Total liabilities and stockholders' equity (deficit)
|
$ | 92,446 | $ | 2,224 | $ | 37,938 | $ | 132,608 | |||||||||
For the year ended December 31, 2009
|
|||||||||||||||||
Pro Forma
|
Pro Forma
|
||||||||||||||||
PLX
|
Teranetics
|
Adjustments
|
Combined
|
||||||||||||||
Net revenues
|
$ | 82,832 | $ | 3,454 | $ | - | $ | 86,286 | |||||||||
Cost of revenues
|
35,900 | 2,495 | - | 38,395 | |||||||||||||
Gross margin
|
46,932 | 959 | - | 47,891 | |||||||||||||
Operating expenses
|
|||||||||||||||||
Research and development
|
31,387 | 14,039 | - | 45,426 | |||||||||||||
Selling, general and administrative
|
24,719 | 3,628 | - | 28,347 | |||||||||||||
Acquisition and restructuring related costs
|
2,900 | - | - | 2,900 | |||||||||||||
Amortization of purchased intangible assets
|
3,416 | - | 8,250 |
(k)
|
11,666 | ||||||||||||
Total operating expenses
|
62,422 | 17,667 | 8,250 | 88,339 | |||||||||||||
Operating loss
|
(15,490 | ) | (16,708 | ) | (8,250 | ) | (40,448 | ) | |||||||||
Interest income
|
622 | 58 | - | 680 | |||||||||||||
Interest expense
|
(450 | ) | (1,139 | ) | (187 | ) |
(l)
|
(637 | ) | ||||||||
1,139 |
(m)
|
||||||||||||||||
Other income (expense), net
|
164 | - | - | 164 | |||||||||||||
Loss on fair value remeasurement
|
(3,842 | ) | - | - | (3,842 | ) | |||||||||||
Loss before provision for income taxes
|
(18,996 | ) | (17,789 | ) | (7,298 | ) | (44,083 | ) | |||||||||
Provision for (benefit from) income taxes
|
(194 | ) | - | - |
(q)
|
(194 | ) | ||||||||||
Net loss
|
$ | (18,802 | ) | $ | (17,789 | ) | $ | (7,298 | ) | $ | (43,889 | ) | |||||
Basic and diluted net loss per share
|
$ | (0.53 | ) | $ | (1.02 | ) | |||||||||||
Shares used to compute basic and diluted per share amounts
|
35,653 | 7,400 | 43,053 | ||||||||||||||
For the nine months ended September 30, 2010
|
|||||||||||||||||
Pro Forma
|
Pro Forma
|
||||||||||||||||
PLX
|
Teranetics
|
Adjustments
|
Combined
|
||||||||||||||
Net revenues
|
$ | 88,774 | $ | 2,638 | $ | - | $ | 91,412 | |||||||||
Cost of revenues
|
37,010 | 1,905 | - | 38,915 | |||||||||||||
Gross margin
|
51,764 | 733 | - | 52,497 | |||||||||||||
Operating expenses
|
|||||||||||||||||
Research and development
|
23,392 | 17,931 | (4,007 | ) |
(n)
|
37,316 | |||||||||||
Selling, general and administrative
|
19,734 | 5,235 | (1,338 | ) |
(n)
|
22,284 | |||||||||||
(1,347 | ) |
(o)
|
|||||||||||||||
Acquisition and restructuring related costs
|
510 | 2,029 | (2,539 | ) |
(p)
|
- | |||||||||||
Amortization of purchased intangible assets
|
1,945 | - | 4,950 |
(k)
|
6,895 | ||||||||||||
Total operating expenses
|
45,581 | 25,195 | (4,281 | ) | 66,495 | ||||||||||||
Operating loss
|
6,183 | (24,462 | ) | 4,281 | (13,998 | ) | |||||||||||
Interest income
|
163 | 2 | - | 165 | |||||||||||||
Interest expense
|
(50 | ) | (6,939 | ) | (30 | ) |
(l)
|
(80 | ) | ||||||||
6,939 |
(m)
|
||||||||||||||||
Other income (expense), net
|
(5 | ) | - | - | (5 | ) | |||||||||||
Income (loss) before provision for income taxes
|
6,291 | (31,399 | ) | 11,190 | (13,918 | ) | |||||||||||
Provision for (benefit from) income taxes
|
1,948 | - | - |
(q)
|
1,948 | ||||||||||||
Net income (loss)
|
$ | 4,343 | $ | (31,399 | ) | $ | 11,190 | $ | (15,866 | ) | |||||||
Basic net income (loss) per share
|
$ | 0.12 | $ | (0.36 | ) | ||||||||||||
Shares used to compute basic per share amounts
|
37,068 | 7,400 | 44,468 | ||||||||||||||
Diluted net income (loss) per share
|
$ | 0.11 | $ | (0.36 | ) | ||||||||||||
Shares used to compute diluted per share amounts
|
37,795 | 7,400 | 44,468 | ||||||||||||||
(727 | ) |
Common Stock
|
Cash at
|
Notes
|
Bridge
|
|||||||||||||||||
of PLX
|
Closing
|
A and B
|
Note
|
Total
|
||||||||||||||||
Purchase price
|
$ | 26,406 | $ | 887 | $ | 6,386 | $ | 1,000 | $ | 34,679 | ||||||||||
Allocated to CEO bonus
|
1,048 | 35 | 264 | - | 1,347 | |||||||||||||||
Payment of assumed liabilities
|
- | 15,879 | - | - | 15,879 | |||||||||||||||
Total
|
$ | 27,454 | $ | 16,801 | $ | 6,650 | $ | 1,000 | $ | 51,905 |
Net liabilities
|
$ | (21,210 | ) | |
Indentifiable intangible assets
|
||||
Existing and core technology
|
20,100 | |||
Customer Relationships
|
10,200 | |||
Trade name
|
200 | |||
In process research and development (1)
|
- | |||
Goodwill
|
25,389 | |||
Total purchase price
|
$ | 34,679 | ||
(1)
|
Current development efforts are not expected to generate positive cash flow contributions
|
Net stockholders' deficit per historical Teranetics financial statements as of 9/30/10
|
$ | (22,560 | ) | |
Adjustment to bridge note (1)
|
1,000 | |||
Adjustment to deferred cost (2)
|
(150 | ) | ||
Adjustment to deferred revenue (2)
|
500 | |||
Net tangible assets
|
$ | (21,210 | ) |
(1)
|
Refer to item (c) in Footnote 3
|
(2)
|
Refer to item (d) in Footnote 3
|
Nine Month
|
Estimated
|
|||||||||||||
Preliminary
|
First Year
|
of Year 2
|
Amortization
|
Useful
|
||||||||||
Fair Value
|
Amortization
|
Amortization
|
Method
|
Life
|
||||||||||
Existing and core technology
|
$ | 20,100 | $ | 3,350 | $ | 2,512 |
Straight line
|
6 Years
|
||||||
Customer Relationships
|
10,200 | 4,800 | 2,363 |
Accelerated
|
3.5 Years
|
|||||||||
Trade Name
|
200 | 100 | 75 |
Straight line
|
2 Years
|
|||||||||
Totals
|
$ | 30,500 | $ | 8,250 | $ | 4,950 |
(a)
|
To record payment at closing to the escrow account and shareholders representative fund.
|
(b)
|
To record payment of notes payable and other assumed liabilities at closing that were required to be paid under the terms of the merger agreement.
|
(c)
|
To adjust the bridge note between PLX and Teranetics entered into during the negotiation to purchase price consideration.
|
(d)
|
To eliminate Teranetics deferred revenue and associated deferred cost for development work on behalf of a customer as no there was no performance obligation required to earn this revenue and no fair value was recorded upon acquisition.
|
(e)
|
To record goodwill for the excess of cost over the fair value of acquired net tangible and intangible assets.
|
(f)
|
To record the preliminary fair values of Teranetics intangible assets acquired.
|
(g)
|
To adjust retention bonus accrual to the chief executive officer for the portion paid in cash and stock at closing and amounts allocated to the notes issued in connection with acquisition to match the distribution to stockholders as per the initial retention and subsequent merger agreement.
|
(h)
|
To record the fair value of the debt issued as part of the merger consideration and the portion related to the chief executive officer retention bonus references in (g) above.
|
(i)
|
To eliminate Teranetics preferred and common stock, paid-in capital and accumulated deficit as of the date of acquisition.
|
(j)
|
To record the issuance of 7.4 million common PLX shares valued at $3.71 per share or $27,454,000
|
(k)
|
To record amortization expense of acquired intangibles resulting from the Teranetics acquisition.
|
(l)
|
To record interest expense related to the notes issued as a part of the merger consideration.
|
(m)
|
To adjust the interest expense of Teranetics line of credit and notes as if the debt was paid as of acquisition as required per the merger agreement.
|
(n)
|
To adjust the Teranetics retention bonus since it is a non-recurring charge recorded in connection with the merger.
|
(o)
|
To adjust the Teranetics' CEO’s bonus under a pre-existing management compensation agreement. since it is a non-recurring charge resulting from the merger.
|
(p)
|
To adjust acquisition related costs incurred prior to acquisition.
|
(q)
|
Since the Company is in a net operating loss position with a fully reserved deferred tax asset, the income tax effect of the adjustments to the proforma statement of operations is assumed to be zero.
|